GlassScriptPhysician profile
Christian Gonzalez
NPI 1376200758
$1,013.69
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $511 · 2023: $486 · 2024: $17.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $297.90 | 2022-2023 | Jardiance, Mounjaro, Emgality |
| Sanofi-Aventis U.S. LLC | $152.00 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $85.26 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $67.76 | 2022 | |
| Abbvie INC. | $54.02 | 2022-2023 | |
| Antares Pharma, INC. | $47.49 | 2023 | Nocdurna, Tlando, Xyosted |
| Glaxosmithkline, LLC. | $46.28 | 2022-2023 | Trelegy Ellipta, Shingrix |
| Idorsia Pharmaceuticals US INC | $36.35 | 2023 | Quviviq |
| Novo Nordisk INC | $33.34 | 2023 | Rybelsus, Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.01 | 2023 | Xifaxan |
| Esperion Therapeutics, INC. | $22.46 | 2022 | |
| Ironwood Pharmaceuticals, INC | $19.70 | 2023 | Linzess |
| Halozyme INC | $19.02 | 2023 | |
| Shield Therapeutics INC | $17.37 | 2023 | Accrufer |
| Angiodynamics, INC. | $17.35 | 2024 | Smart Port Ct |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $16.45 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $14.33 | 2023 | Rexulti |
| Medtronic, INC. | $14.01 | 2023 | Vanta Adaptivestim |
| Astrazeneca Pharmaceuticals LP | $12.51 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.